1. Home
  2. DAKT vs QURE Comparison

DAKT vs QURE Comparison

Compare DAKT & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$18.90

Market Cap

872.1M

Sector

Industrials

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$19.84

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
QURE
Founded
1968
1998
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
872.1M
1.9B
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
DAKT
QURE
Price
$18.90
$19.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
12
Target Price
$26.00
$58.55
AVG Volume (30 Days)
395.9K
2.4M
Earning Date
12-10-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$770,283,000.00
$15,751,000.00
Revenue This Year
$12.94
N/A
Revenue Next Year
$7.16
$158.05
P/E Ratio
$128.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.24
$7.76
52 Week High
$24.38
$71.50

Technical Indicators

Market Signals
Indicator
DAKT
QURE
Relative Strength Index (RSI) 50.83 25.66
Support Level $17.09 $20.55
Resistance Level $21.28 $28.50
Average True Range (ATR) 0.87 1.47
MACD 0.23 0.12
Stochastic Oscillator 44.13 4.43

Price Performance

Historical Comparison
DAKT
QURE

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Share on Social Networks: